The Pharmacology of Longevity: Peptide Edition (Part 1) FDA Peptide Ban Lifted: Legit Compounding Pharmacies Now Regulate Julian Becerra posted on the topic LinkedIn FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner HIMS: Regulatory Arbitrage and the Future of Personalized Medicine FDA Removes Key Peptides from Category 2: What This Means for You